MedWatch

Boost for Medtronic's Parkinson's treatment

A new study shows that treatment with deep brain stimulation can improve the life quality of Parkinson’s patients even in the early stages of the disease.

Foto: Medtronic/ PR

New research gives hope of an improved life quality for people suffering from motor complications due to Parkinson’s disease, Medtronic writes in a press release. The Medtech giant’s Deep Brain Stimulation (DBS) treatment formed the basis of the new study. The technique sees doctors using an implant similar to a pacemaker to transfer mild electrical impulses to specific areas of the brain, the company explains.

The clinical trial included 251 people with Parkinson’s disease at 17 centers in Germany and France and followed them over the course of two years. The results of the clinical trial was published in the latest issue of The New England Journal of Medicine.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier